GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ovation Science Inc (XCNQ:OVAT) » Definitions » Enterprise Value

Ovation Science (XCNQ:OVAT) Enterprise Value : C$1.30 Mil (As of Nov. 14, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Ovation Science Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ovation Science's Enterprise Value is C$1.30 Mil. Ovation Science's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was C$-0.59 Mil. Therefore, Ovation Science's EV-to-EBIT ratio for today is -2.20.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Ovation Science's Enterprise Value is C$1.30 Mil. Ovation Science's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was C$-0.59 Mil. Therefore, Ovation Science's EV-to-EBITDA ratio for today is -2.22.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Ovation Science's Enterprise Value is C$1.30 Mil. Ovation Science's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was C$0.10 Mil. Therefore, Ovation Science's EV-to-Revenue ratio for today is 12.89.


Ovation Science Enterprise Value Historical Data

The historical data trend for Ovation Science's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovation Science Enterprise Value Chart

Ovation Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial 3.90 8.89 1.11 0.75 1.33

Ovation Science Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 1.06 1.33 1.93 1.13

Competitive Comparison of Ovation Science's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Ovation Science's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ovation Science's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ovation Science's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Ovation Science's Enterprise Value falls into.



Ovation Science Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Ovation Science's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Ovation Science's Enterprise Value for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ovation Science  (XCNQ:OVAT) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Ovation Science's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1.302/-0.591
=-2.20

Ovation Science's current Enterprise Value is C$1.30 Mil.
Ovation Science's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.59 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Ovation Science's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=1.302/-0.587
=-2.22

Ovation Science's current Enterprise Value is C$1.30 Mil.
Ovation Science's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.59 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Ovation Science's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1.302/0.101
=12.89

Ovation Science's current Enterprise Value is C$1.30 Mil.
Ovation Science's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ovation Science Enterprise Value Related Terms

Thank you for viewing the detailed overview of Ovation Science's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Ovation Science Business Description

Traded in Other Exchanges
Address
1166 Alberni Street, Suite 1003, Vancouver, BC, CAN, V6E 3Z3
Ovation Science Inc is a Canada-based company mainly engaged in the business of providing topical and transdermal cannabis products under the "Ovation" brand label utilizing patented "Invisicare" delivery technology which it acquired for exclusive use for cannabis formulated products. The group has two geographical segment Canada and United States. Key revenue is generated from Canada.
Executives
Doreen Mcmorran Director
Ian Howard Director
David K. Ryan Director

Ovation Science Headlines

No Headlines